In the era of coronavirus disease 2019 (COVID-19), the management of cardiac implantable electronic devices infections with concomitant viral infection has not been completely defined yet. In this explorable context, we report the first experience of a Cardiac resynchronization therapy with defibrillator (CRT-D) implantation after transvenous lead extraction for endocarditis in a COVID-19 patient. We describe both the measures and procedures implemented to reduce the cross-infection in the operating room and our clinical practice to improving procedure effectiveness on patient care.
Keywords: cardiac resynchronization therapy with defibrillator; cardiovascular implantable electronic devices; covid-19; endocarditis; transvenous lead extraction.
© 2021 Wiley Periodicals LLC.